VBI Vaccines Inc.

NASDAQ: VBIV
Share price (5/3/24): $0.58
Market cap (5/3/24): $16.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

Late annual filing notification for FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Exempt offering of securities

Ownership Filter

Perceptive Advisors LLC

Perceptive Advisors LLC

News Filter

Reports Full Year 2023 Financial Results

Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma

Announces Expanded Strategic Partnership With Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission – amended

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC